Breast cancer - Clinical early disease Neoadjuvant versus adjuvant chemotherapy for women with operable breast cancer: a matched-pair analysis and prognostic factors on overall survival

被引：0
|
作者：
Arnaud, A.
Crehange, G.
Dabakuyo, S. [1 ]
Coudert, B.
Peignaux, K.
Truc, G.
Arveux, P. [2 ]
Bonnetain, F. [1 ]
Maingon, P. [1 ]
机构：
[1] Ctr Georges Francois Leclerc, Biostat & Epidemiol Unit, Dijon, France
[2] Ctr Georges Francois Leclerc, Breast & Gynecol Canc Registry Cote Dor, Dijon, France
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)71062-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：311 / 311
页数：1
相关论文
共 50 条
  • [1] Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer:: the role of clinical response
    Pierga, JY
    Mouret, E
    Laurence, V
    Diéras, V
    Savigioni, A
    Beuzeboc, P
    Dorval, T
    Palangié, T
    Jouve, M
    Pouillart, P
    [J]. EUROPEAN JOURNAL OF CANCER, 2003, 39 (08) : 1089 - 1096
  • [2] Male Breast Cancer Prognostic Factors Versus Female Counterparts with Propensity Scores and Matched-Pair Analysis
    Yu, Edward
    Stitt, Larry
    Vujovic, Olga
    Joseph, Kurian
    Assouline, Avi
    Younus, Jawaid
    Perera, Francisco
    Tai, Patricia
    [J]. CUREUS, 2015, 7 (10):
  • [3] Survival Outcome of Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy in Early Triple Negative Breast Cancer
    Huang, Kai
    Jakub, James W.
    Gabriel, Emmanuel
    Moreno-Aspitia, Alvaro
    McLaughlin, Sarah
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S120 - S120
  • [4] Prognostic Factors in Operable Breast Cancer Treated with Neoadjuvant Chemotherapy: Towards a Quantification of Residual Disease
    Mombelli, Sarah
    Kwiatkowski, Fabrice
    Abrial, Catherine
    Wang-Lopez, Qian
    de Boissieu, Paul
    Garbar, Christian
    Bensussan, Armand
    Cure, Herve
    [J]. ONCOLOGY, 2015, 88 (05) : 261 - 272
  • [5] Prognostic factors in patients with operable breast cancer who received neoadjuvant chemotherapy
    Horiguchi, J.
    Takata, D.
    Nagaoka, R.
    Fujii, T.
    Sato, A.
    Tokiniwa, H.
    Higuchi, T.
    Uchida, S.
    Tsuboi, M.
    Yajima, R.
    Kikuchi, M.
    Ino, Y.
    Oyama, T.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 57 : S94 - S94
  • [6] Neoadjuvant or adjuvant chemotherapy in early breast cancer?
    Montemurro, Filippo
    Nuzzolese, Imperia
    Ponzone, Riccardo
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (09) : 1071 - 1082
  • [7] Clinical prognostic and predictive factors for primary chemotherapy in operable breast cancer
    Ellis, P
    Smith, I
    Ashley, S
    Walsh, G
    Ebbs, S
    Baum, M
    Sacks, N
    McKinna, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) : 107 - 114
  • [8] Early breast cancer patients benefit more from longer course chemotherapy: a matched-pair analysis
    Wang, Yaohui
    Yin, Wenjin
    Lin, Yanping
    Zhou, Liheng
    Du, Yueyao
    Yin, Kai
    Lu, Jinsong
    [J]. FUTURE ONCOLOGY, 2019, 15 (15) : 1781 - 1789
  • [9] ADJUVANT CHEMOTHERAPY FOR OPERABLE BREAST-CANCER IN PREMENOPAUSAL WOMEN
    FALKSON, HC
    FALKSON, G
    PORTUGAL, MA
    SCHOEMAN, HS
    [J]. SOUTH AFRICAN MEDICAL JOURNAL, 1982, 61 (18): : 651 - 655
  • [10] Male Breast Cancer Prognostic Factors: Similarity to Female Counterparts With Propensity Scores and Matched-Pair Analysis
    Yu, E.
    Stitt, L.
    Vujovic, O.
    Joseph, K.
    Assouline, A.
    Au, J.
    Younus, J.
    Perera, F.
    Tai, P.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S221 - S221
12345